Enlivex Therapeutics Ltd. (TLV:ENLV)
Israel · Delayed Price · Currency is ILS · Price in ILA 349.30
0.00 (0.00%)
Oct 5, 2025, 3:52 PM IDT
Enlivex Therapeutics Market Cap
Enlivex Therapeutics has a market cap or net worth of 89.47 million as of October 7, 2025. Its market cap has decreased by -26.94% in one year.
Market Cap
89.47M
Enterprise Value
27.15M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
349.30
Market Cap Chart
Since March 26, 2019, Enlivex Therapeutics's market cap has decreased from 368.04M to 89.47M, a decrease of -75.69%. That is a compound annual growth rate of -19.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 88.49M | -5.57% |
| Dec 31, 2024 | 93.71M | -48.18% |
| Dec 29, 2023 | 180.84M | -29.06% |
| Dec 30, 2022 | 254.92M | -28.46% |
| Dec 31, 2021 | 356.33M | -8.65% |
| Dec 31, 2020 | 390.07M | 30.23% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 75.93B |
| Danel (Adir Yeoshua) | 3.10B |
| Kamada | 1.31B |
| Bait Bakfar | 1.01B |
| BrainsWay | 977.55M |
| SofWave Medical | 960.10M |
| Ilex Medical | 714.47M |
| Novolog (Pharm-Up 1966) | 649.83M |